Detailansicht
Severe Infections Caused by Pseudomonas aeruginosa
Perspectives on Critical Care Infectious Diseases 7
ISBN/EAN: 9781402074219
Umbreit-Nr.: 1590327
Sprache:
Englisch
Umfang: xiii, 236 S.
Format in cm:
Einband:
gebundenes Buch
Erschienen am 31.03.2003
- Zusatztext
- InhaltsangabeContributors. Preface; A.R. Hauser, J. Rello. Series Preface; J. Rello. 1. Pseudomonas aeruginosa Infections in Specific Types of Patients and Clinical Settings; M.E. Stryjewski, D.J. Sexton. 2. The Spectrum of Pseudoinonas aeruginosa Disease; J. Roig, M. Sabria. 3. Hospital-Acquired Pneumonia Caused by Pseudomonas aeruginosa: North American Perspective; G.W. Waterer, R.G. Wunderink. 4. Hospital-Acquired Pneumonia Caused by Pseudomonas aeruginosa: European Perspective; E. Diaz, J. Rello, J. Vallès. 5. Pseudomonas aeruginosa Infections in Individuals With Cystic Fibrosis: North American Perspective; D.J. Davidson, A.J. Currie, D.P. Speert. 6. Pseudomonas aeruginosa Infections in Individuals With Cystic Fibrosis: European Perspective; M. Bosque, Ò. Asensio. 7. Pseudomonas aeruginosa Infections in Cancer Patients; K.V.I. Rolston. 8. Treatment of Serious Pseudomonas aeruginosa Infections: North American Perspective; P. Voirol, B.J. Guglielmo. 9. Treatment of Serious Pseudomonas aeruginosa Infections: European Perspective; G. Höffken. 10. Epidemiology and Control of Pseudomonas aeruginosa Infections in the Intensive Care Unit: North American Perspective; W.R. Jarvis. 11. Epidemiology and Control of Pseudomonas aeruginosa Infections in the Intensive Care Unit: European Perspective; D. Talon, X. Bertrand. 12. New Perspectives on Prevention and Management of Pseudomonas aeruginosa Infections; K.P. Rumbaugh, T. Sawa, J.P. Wiener-Kronish. 13.Molecular Pathogenesis of Acute Pseudomonas aeruginosa Infections; J.N. Engel. Index.
- Kurztext
- Emphasizes controversies in the diagnosis, treatment, prevention and pathogenesis of pseudomonas aeruginosa infections. This book focuses on topics such as the diagnosis of hospital-acquired pneumonia, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, and more.